Survanta (AbbVie Inc.)


Welcome to the PulseAid listing for the Survanta drug offered from AbbVie Inc.. This Alveolar Surface Tension Reduction [PE],Surfactant [EPC],Surfactant Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.




LABELER NAME / MANUFACTURER: AbbVie Inc.
NON-PROPRIETARY NAME: Beractant
SUBSTANCE NAME: BERACTANT
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alveolar Surface Tension Reduction [PE],Surfactant [EPC],Surfactant Activity [MoA]
ROUTE: ENDOTRACHEAL
DOSAGE FORM: SUSPENSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1991-07-01
END MARKETING DATE: 0000-00-00


Survanta HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSurvanta from AbbVie Inc.
LABELER NAME: AbbVie Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 25(mg/mL)
START MARKETING DATE: 1991-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0074-1040_76876f21-08b6-9dfe-8dda-901496585239
PRODUCT NDC: 0074-1040
APPLICATION NUMBER: NDA020032

Other BERACTANT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AbbVie Inc.Survanta